Less Ads, More Data, More Tools Register for FREE

Pin to quick picksACRL.L Regulatory News (ACRL)

  • There is currently no data for ACRL

Director Shareholding

4 Apr 2018 17:06

RNS Number : 8632J
Accrol Group Holdings PLC
04 April 2018
 

4 April 2018

 

Accrol Group Holdings plc

 

(the "Company")

 

Director Shareholding

 

Accrol Group Holdings plc (AIM: ACRL), the AIM-listed independent tissue converter, announces that Dan Wright, Executive Chairman, has advised the Company that he has transferred 415,168 shares in the Company in which he was the direct beneficial owner into the ownership of Gomrath Ltd, a Family Investment Company that he controls.

 

The total shares owned and deemed to be under the control of Dan Wright remains unchanged.

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Dan Wright

2

Reason for the notification

a)

Position/status

Executive Chairman

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Accrol Group Holdings plc

b)

LEI

213800MC56M5G69RJ226

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.001

 

ISIN: GB00BZ6VT592

b)

Nature of the transaction

Transfer of shares

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

18.52p

415,168

d)

Aggregated information

- Aggregated volume

- Price

N/A - single transaction

e)

Date of the transaction

4 April 2018

f)

Place of the transaction

London Stock Exchange, AIM

 

 

 

For further information, please contact:

Accrol Group Holdings plc

Gareth Jenkins, Chief Executive Officer

+44 (0) 1254 278 844

Martin Leitch, Interim Chief Finance Officer

+44 (0) 1254 278 844

Zeus Capital Limited (Nominated Adviser & Broker) 

Dan Bate / Andrew Jones

 +44 (0) 161 831 1512

Dominic King / John Goold

+44 (0) 203 829 5000

Belvedere Communications Limited

Cat Valentine (cvalentine@belvederepr.com)

+44 (0) 7715 769 078

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEAKLLEEDPEFF
Date   Source Headline
26th Jun 20179:06 amRNSInvestment in new manufacturing line for Leyland
23rd Jun 201710:15 amEQSLily & Piper Limited: Small Cap Awards 2017
16th May 20177:00 amRNSTrading Update, New Facilities & Notice of Results
6th Apr 201712:00 pmRNSOfficial opening of new manufacturing facility
9th Jan 20173:43 pmRNSHolding(s) in Company
4th Jan 20177:00 amRNSInterim results for six months ended 31 Oct 2016
14th Dec 20167:00 amRNSNotice of interim results date change
7th Nov 20167:00 amRNSPre-close trading statement
30th Sep 201612:07 pmRNSResult of AGM
29th Sep 20164:33 pmRNSDirector's Dealing
22nd Sep 20161:06 pmRNSHolding(s) in Company
2nd Sep 20167:00 amRNSNew manufacturing facility
4th Aug 20164:56 pmRNSHolding(s) in Company
22nd Jul 20167:00 amRNSFull year results for the year ended 30 April 2016
11th Jul 20167:00 amRNSDeferred Share Buyback
8th Jul 20167:00 amRNSContract Win and Trading Update
14th Jun 20165:12 pmRNSHolding(s) in Company
13th Jun 20166:18 pmRNSHolding(s) in Company
13th Jun 20166:01 pmRNSHolding(s) in Company
13th Jun 20165:57 pmRNSHolding(s) in Company
13th Jun 20164:03 pmRNSHolding(s) in Company
13th Jun 20161:45 pmRNSHolding(s) in Company
13th Jun 201612:28 pmRNSHolding(s) in Company
10th Jun 20167:00 amRNSFirst Day of Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.